These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 232917)

  • 1. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
    Bulla M; Delling G; Offermann G; Ziegler R; Benz G; Lühmann H; Sanchez de Reutter A; Severin M
    Proc Eur Dial Transplant Assoc; 1979; 16():644-8. PubMed ID: 232917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA
    Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients].
    Fünfstück R; Günther K; Tietz U; Brandstädt A; Stein G; Hartwich R
    Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology.
    Malluche HH; Ritz E; Werner E; Meyer-Sabellek WA
    Clin Nephrol; 1978 Dec; 10(6):219-28. PubMed ID: 215365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corneal deposits in children on dialysis and treatment with vitamin D3 and 1,25 DHCC (author's transl)].
    Severin M; Bulla M
    Klin Monbl Augenheilkd; 1979 Nov; 175(5):670-6. PubMed ID: 232733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
    Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD
    Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of bile on intestinal calcium and vitamin D absorption. Animal experiment studies in swine].
    Braun F
    Wien Klin Wochenschr Suppl; 1986; 166():1-23. PubMed ID: 3008448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
    Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G
    Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for skeletal resistance to vitamin D in renal failure.
    Weisbrode SE; Capen CC
    Fed Proc; 1976 Apr; 35(5):1225-31. PubMed ID: 177317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
    Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
    Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
    Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
    Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.